Volume 30, Supplement - Infectious Diseases and Carceral Health
SUPPLEMENT ISSUE
Prevention
Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States
Figure

Figure. Timeline of hepatitis C virus screening recommendations and treatments that advance hepatitis C elimination in carceral settings, United States. Colored circles on the timeline indicate the year certain recommendations were made or hepatitis C treatments were approved. Other symbols are pictorial representations. CDC, Centers for Disease Control and Prevention; DAA, direct-acting antiviral; FDA, Food and Drug Administration; HCV, hepatitis C virus.
Page created: December 31, 2023
Page updated: March 31, 2024
Page reviewed: March 31, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.